A Study to Derive Normative Distribution of CIMT and to Determine Its Correlation With Cardiovascular Risk Factors
NCT ID: NCT01551875
Last Updated: 2013-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1200 participants
OBSERVATIONAL
2012-05-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
All the procedures could be completed in a single day, however due to any reason any study variable is not taken subject may be asked to come back for a second visit within 7 days of the first visit.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Subclinical COronary Atherosclerosis for Risk Stratification Using Coronary Computed Tomography (CT) Angiography
NCT01416532
The Association Between Central Aortic Blood Pressure Indices and Severity of Coronary Artery Disease
NCT02471768
Coronary Artery Geometry and the Severity of Coronary Atherosclerosis
NCT04185493
Correlation Between the Severity of Coronary Artery Disease and Peripheral Arterial Stiffness in Patients With Premature Coronary Heart Disease
NCT04578522
Correlation of Biomarkers With the Presence and Severity of Coronary Artery Disease
NCT05015270
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
subjects who are meeting the inclusion criteria
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female or male aged 30 years and over
Exclusion Criteria
* Intake of lipid lowering drug in the past 3 month
* Subjects with known hypersensitivity to carotid bulb
* Pregnant or lactating women
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paurus M Irani, MD
Role: STUDY_DIRECTOR
AstraZeneca Pharma India Ltd.
R R Kasliwal, DM
Role: PRINCIPAL_INVESTIGATOR
Medanta, The Medicity, Gurgaon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Ahmedabad, Gujarat, India
Research Site
Vadodara, Gujarat, India
Research Site
Gurgaon, Haryana, India
Research Site
Keshwāpur, Hubli, India
Research Site
Nampally, Hyderabad, India
Research Site
Punjab, Jalanhar, India
Research Site
Bangalore, Karnataka, India
Research Site
Mangalore, Karnataka, India
Research Site
Mumbai, Maharashtra, India
Research Site
Nerul, Navi Mumbai, India
Research Site
Delhi, New Delhi, India
Research Site
Dhanvantri Nagar, Puducherry, India
Research Site
Jipur, Rajasthan, India
Research Site
Chennai, Tamil Nadu, India
Research Site
Poonkunnam, Thrisur, India
Research Site
Pattom, Trivandum, India
Research Site
Ghaziabad, Uttar Pradesh, India
Research Site
Noida, Uttar Pradesh, India
Research Site
Varanasi, Uttar Pradesh, India
Research Site
Kolkata, West Bengal, India
Research Site
Chandigarh, , India
Research Site
Indore, , India
Research Site
Lucknow, , India
Research Site
Pune, , India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Score-India
Identifier Type: -
Identifier Source: secondary_id
NIS-CIN-XXX-2011/2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.